(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.36%) $78.76
(-1.28%) $2.17
(0.08%) $2 333.10
(0.06%) $27.63
(0.85%) $973.10
(0.06%) $0.929
(0.16%) $10.84
(0.06%) $0.796
(0.00%) $91.35
Quarter results tomorrow
(bmo 2024-05-08)
Expected move: +/- 0.00%
0.04% ¥ 1 264.00
Live Chart Being Loaded With Signals
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products...
Stats | |
---|---|
Dzisiejszy wolumen | 144 600 |
Średni wolumen | 618 080 |
Kapitalizacja rynkowa | 206.15B |
EPS | ¥0 ( 2024-02-07 ) |
Następna data zysków | ( ¥14.64 ) 2024-05-08 |
Last Dividend | ¥8.50 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 22.74 |
ATR14 | ¥0.476 (0.04%) |
Wolumen Korelacja
Nipro Corporation Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nipro Corporation Korelacja - Waluta/Towar
Nipro Corporation Finanse
Annual | 2022 |
Przychody: | ¥545.20B |
Zysk brutto: | ¥163.45B (29.98 %) |
EPS: | ¥28.04 |
FY | 2022 |
Przychody: | ¥545.20B |
Zysk brutto: | ¥163.45B (29.98 %) |
EPS: | ¥28.04 |
FY | 2022 |
Przychody: | ¥494.79B |
Zysk brutto: | ¥149.27B (30.17 %) |
EPS: | ¥82.50 |
FY | 2021 |
Przychody: | ¥455.56B |
Zysk brutto: | ¥138.84B (30.48 %) |
EPS: | ¥87.12 |
Financial Reports:
No articles found.
Nipro Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥13.50 (N/A) |
¥0 (N/A) |
¥8.50 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥8.75 | 2001-03-27 |
Last Dividend | ¥8.50 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 45 | -- |
Total Paid Out | ¥561.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.13 | -- |
Div. Sustainability Score | 7.70 | |
Div.Growth Potential Score | 3.48 | |
Div. Directional Score | 5.59 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8050.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7294.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
6540.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
5852.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4553.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3788.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3050.T | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
1930.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
9474.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8383.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0177 | 1.500 | 9.65 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00921 | 1.200 | 9.69 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0455 | 1.500 | -0.605 | -0.908 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.495 | 0.800 | 7.52 | 6.02 | [1 - 3] |
quickRatioTTM | 0.717 | 0.800 | -0.486 | -0.389 | [0.8 - 2.5] |
cashRatioTTM | 0.222 | 1.500 | 9.88 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.539 | -1.500 | 1.023 | -1.534 | [0 - 0.6] |
interestCoverageTTM | 4.49 | 1.000 | 9.45 | 9.45 | [3 - 30] |
operatingCashFlowPerShareTTM | 686.29 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 686.29 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 2.46 | -1.500 | 0.157 | -0.236 | [0 - 2.5] |
grossProfitMarginTTM | 0.300 | 1.000 | 8.33 | 8.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0466 | 1.000 | -1.069 | -1.069 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.187 | 1.000 | -0.0728 | -0.0728 | [0.2 - 2] |
assetTurnoverTTM | 0.520 | 0.800 | 9.87 | 7.89 | [0.5 - 2] |
Total Score | 7.70 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 20.12 | 1.000 | 8.07 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0455 | 2.50 | -0.389 | -0.908 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 686.29 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.979 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 686.29 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -3.79 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.194 | 1.000 | 7.66 | 0 | [0.1 - 0.5] |
Total Score | 3.48 |
Nipro Corporation
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej